Epidermal growth factor receptor inhibitors: A review of cutaneous adverse events and management
Epidermal growth factor inhibitors (EGFRI), the first targeted cancer therapy, are currently an essential treatment for many advance-stage epithelial cancers. These agents have the superior ability to target cancers cells and better safety profile compared to conventional chemotherapies. However, cu...
Saved in:
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34433 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Mahidol University |
Be the first to leave a comment!